Reinventing Life Science Startups – Evidence-based Entrepreneurship
Steve Blank
AUGUST 21, 2013
In the real world a big pivot in life sciences far down the road of development is a very bad sign due to huge sunk costs. Other pivots involved moving from a platform technology to become a product supplier, moving from a therapeutic drug to a diagnostic or moving from a device that required a PMA to one that required a 510(k).
Let's personalize your content